Financial Performance - The company's operating revenue for 2023 was ¥526,200,402.55, a decrease of 22.16% compared to ¥676,040,494.39 in 2022[23] - The net profit attributable to shareholders for 2023 was ¥108,791,131.72, down 38.82% from ¥177,824,990.70 in the previous year[23] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 15.85% to ¥93,022,187.27 from ¥80,294,390.93 in 2022[23] - The net cash flow from operating activities for 2023 was ¥86,344,182.88, an increase of 12.36% compared to ¥76,848,469.98 in 2022[23] - Basic earnings per share for 2023 were ¥0.81, a decrease of 39.10% from ¥1.33 in 2022[23] - The weighted average return on net assets for 2023 was 6.17%, down from 10.93% in the previous year[23] Assets and Liabilities - The total assets at the end of 2023 were ¥2,039,438,290.26, reflecting a growth of 10.40% from ¥1,847,310,297.11 at the end of 2022[23] - The net assets attributable to shareholders at the end of 2023 were ¥1,819,379,854.45, up 6.26% from ¥1,712,261,984.50 in 2022[23] - Cash and cash equivalents decreased by 3,462.27% to a net reduction of ¥474,642,084.20 in 2023[99] - As of the end of 2023, accounts receivable amounted to ¥95,443,107.59, representing 4.68% of total assets, a slight increase from 4.67% at the beginning of the year[104] - Inventory increased to ¥118,509,810.58, accounting for 5.81% of total assets, down from 6.13% at the beginning of the year, reflecting a decrease of 0.32%[104] Research and Development - In 2023, the company introduced 14 graduate-level R&D personnel and 1 PhD, enhancing its R&D capabilities, and applied for 7 new invention patents, totaling 22 effective patents[39] - Research and development investment amounted to CNY 26.13 million, accounting for 4.97% of operating revenue, focusing on new products and processes[81] - The number of R&D personnel increased by 62% from 50 in 2022 to 81 in 2023, with a significant rise in higher degree holders[96] - The company has completed several R&D projects aimed at enhancing CO2 adsorption capacity and developing high-temperature resistant materials[95] Market and Industry Trends - The ion exchange and adsorption resin industry is experiencing increasing demand due to applications in high-end industrial water, food and drinking water, and environmental protection[34] - The market for ion exchange and adsorption resins is expanding, driven by national strategies and the transition to clean energy, with applications in lithium, nickel, and cobalt extraction[35] - The semiconductor and pharmaceutical industries are significant growth areas for the company, with increasing demand for ultra-pure water and biopharmaceutical resins[36] - The downstream demand for ion exchange and adsorption resins is expected to grow due to the expansion of industries such as food and beverage, nuclear power, and biomedicine[46] Production and Quality Management - The production process for ion exchange and adsorption resins is complex, requiring strict control over raw materials and production techniques to ensure product quality[37] - The company maintains a robust quality management system, certified under ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018, ensuring high product quality[40] - The company has established a procurement model of "production based on sales and purchasing based on production, while considering safety stock" to enhance production flexibility[48] Investment and Capital Management - The company reported a total investment of ¥1,876,103,362.67 during the reporting period, a decrease of 22.35% compared to ¥2,416,239,836.35 in the same period last year[107] - The company has committed to an investment of 13,600 million yuan for the food-grade resin production line, with a completion progress of 76.54% as of November 30, 2023[112] - The total amount of raised funds was ¥121,033.34 million, with a net amount of ¥109,997.56 million after deducting fees[111] Corporate Governance - The company has implemented a strict information disclosure management system, ensuring that all shareholders have equal access to information through designated media[139] - The company has established independent financial and personnel management systems, ensuring no overlap with the controlling shareholders' enterprises[146][145] - The company has a diverse board with members having extensive backgrounds in finance and management, including independent directors with qualifications as certified public accountants[157] Employee Management and Training - The total number of employees at the end of the reporting period was 367, with 41 in the parent company and 326 in major subsidiaries[176] - The company has implemented a comprehensive salary system that includes basic salary, performance pay, overtime pay, and various allowances, ensuring compliance with national labor laws[178] - In 2023, the company conducted safety training for all new employees and organized two full staff training sessions covering various topics including legal regulations and safety knowledge[179] Dividend and Profit Distribution - The company plans to distribute a cash dividend of 2.60 CNY per 10 shares, amounting to 34,688,545.84 CNY (including tax), which represents 31.89% of the net profit attributable to shareholders[186] - The total distributable profit for the year is reported at 348,249,563.82 CNY, with the cash dividend constituting 100% of the profit distribution[183] - The cash dividend distribution plan was approved by the board and shareholders, ensuring compliance with relevant laws and regulations[182] Risk Management - The company has no significant risks related to major assets, core technologies, or ongoing legal disputes that could impact its continued operations[151] - The company emphasizes the importance of maintaining effective internal controls to mitigate risks and ensure regulatory compliance[199]

Financial Performance - The company's revenue for Q1 2024 was ¥118,104,468.14, representing a slight increase of 0.23% compared to ¥117,831,217.78 in the same period last year[5] - Net profit attributable to shareholders increased by 26.81% to ¥26,177,483.07 from ¥20,642,891.60 year-on-year[5] - The net cash flow from operating activities rose by 32.97% to ¥17,296,739.60, up from ¥13,007,678.27 in Q1 2023[5] - Basic and diluted earnings per share both increased by 33.33% to ¥0.20 from ¥0.15 in the previous year[5] - Total operating revenue for Q1 2024 was CNY 118,104,468.14, a slight increase from CNY 117,831,217.78 in the previous period, representing a growth of approximately 0.23%[21] - The net profit for Q1 2024 was CNY 26,177,483.07, representing a 26.0% increase compared to CNY 20,642,891.60 in Q1 2023[22] - Operating profit for Q1 2024 was CNY 31,210,632.15, up from CNY 25,164,576.09 in the same period last year, indicating a growth of 24.0%[22] - The total profit before tax for Q1 2024 was CNY 31,211,384.49, compared to CNY 25,231,788.50 in Q1 2023, reflecting a growth of 23.6%[22] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥2,042,032,824.06, a 0.13% increase from ¥2,039,438,290.26 at the end of the previous year[5] - Total liabilities decreased to CNY 199,862,314.58 from CNY 220,058,435.81, representing a reduction of approximately 9.16%[20] - The total equity attributable to shareholders increased to CNY 1,842,170,509.48 from CNY 1,819,379,854.45, marking a growth of about 1.25%[20] Cash Flow - Cash flow from operating activities generated a net amount of CNY 17,296,739.60, compared to CNY 13,007,678.27 in Q1 2023, reflecting a 32.0% increase[24] - The company experienced a negative cash flow from financing activities of CNY -6,988,124.11, compared to a positive cash flow of CNY 2,953,581.17 in Q1 2023[25] - The total cash inflow from investment activities was CNY 417,215,552.45, significantly higher than CNY 130,347,375.90 in the previous year[24] - The company reported a net cash outflow from investment activities of CNY -26,553,257.99, an improvement from CNY -342,956,169.09 in Q1 2023[24] Research and Development - Research and development expenses surged by 53.22% to ¥7,233,115.31 compared to ¥4,720,839.29 in Q1 2023, indicating increased investment in innovation[11] - Research and development expenses rose significantly to CNY 7,233,115.31 from CNY 4,720,839.29, reflecting an increase of approximately 53.3%[21] Shareholder Information - The total number of common shareholders at the end of the reporting period is 12,698[13] - The largest shareholder, Shen Jianhua, holds 51.97% of the shares, amounting to 69,480,000 shares[13] - The company has a significant concentration of ownership, with the top three shareholders holding a combined 71.93% of the shares[13] - The company has not disclosed any related party relationships among the top shareholders[13] Stock Repurchase - The company plans to repurchase shares with a total fund of no less than 10 million and no more than 20 million RMB, with a maximum repurchase price of 36.00 RMB per share[16] - As of March 31, 2024, the company has repurchased 276,000 shares, representing 0.21% of the total share capital[16] - The highest transaction price during the repurchase was 21.48 RMB per share, and the total amount spent was 5,784,398 RMB[16] - The company is implementing a stock buyback plan to support employee stock ownership and equity incentives[16] - The company’s stock repurchase program is expected to range from 277,800 to 555,600 shares based on the maximum repurchase price and total fund limits[16] Other Financial Metrics - Cash and cash equivalents decreased to CNY 620,140,896.68 from CNY 797,543,615.39, a decline of approximately 22.24%[19] - The company's inventory decreased to CNY 112,128,084.05 from CNY 118,509,810.58, indicating a reduction of about 5.39%[19] - The company has maintained a stable level of deferred tax assets at CNY 5,090,443.78, unchanged from the previous period[19] - The total number of restricted shares at the end of the period is 90,837,600 shares, with no changes during the reporting period[15] - The company received government subsidies amounting to ¥5,476,006.78 during the quarter, contributing to its financial performance[7] - Investment income decreased by 56.21% to ¥693,990.71, down from ¥1,584,806.03, reflecting reduced gains from financial assets[11] - The company reported a 35.60% increase in contract liabilities, reaching ¥13,090,746.27, attributed to higher prepayments received[11] - The company’s total cash and cash equivalents at the end of Q1 2024 were CNY 264,182,462.31, down from CNY 426,447,739.15 at the end of Q1 2023[25]

二、监事会对公司 2023 年度有关事项的意见 （一）公司规范运作情况 浙江争光实业股份有限公司 2023 年度监事会工作报告 2023 年度，浙江争光实业股份有限公司（以下简称"公司"）监事会按照《中 华人民共和国公司法》等法律、法规以及《浙江争光实业股份有限公司章程》《浙 江争光实业股份有限公司监事会议事规则》等规章制度的规定，从切实维护公司 利益的角度出发，本着对全体股东认真负责的原则，认真履行有关法律、法规赋 予的职权，对公司主要生产经营活动、财务状况以及董事和高级管理人员履行职 责情况进行了检查和监督，现将监事会 2023 年主要工作内容汇报如下： 一、2023 年度监事会工作情况 2023 年度，公司监事会共召开监事会 7 次，会议的召开、表决和决议程序 严格按照《中华人民共和国公司法》《浙江争光实业股份有限公司章程》及相关 法律法规的规定规范运作，会议合法、有效。具体情况如下： | 序号 | 会议届次 | | 召开日期 | | 会议决议 | | --- | --- | --- | --- | --- | --- | | | | | | | 1、审议《关于<2022 年度监事会工作报告>的议案》 ...

根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治 理准则》《国有企业、上市公司选聘会计师事务所管理办法》和《公司章程》 等相关规定，公司董事会审计委员会本着勤勉尽责的原则，认真履行了审计监 督职责。现将董事会审计委员会对会计师事务所2023年度履行监督职责的情况 汇报如下： 一、2023年年审会计师事务所基本情况 浙江争光实业股份有限公司 审计委员会对会计师事务所2023年度履职情况 履行监督职责情况的报告 二、审计委员会对会计师事务所监督职责情况 2023年4月19日，第五届董事会审计委员会第八次会议审议通过《关于续聘 2023年度审计机构的议案》，董事会审计委员会查阅了天健会计师事务所有关 资格证照、相关信息，认为其具备足够的专业胜任能力、投资者保护能力、独 立性，具备证券相关业务审计资格，能够满足公司2023年度审计工作的质量要 求。为保证审计工作的质量和连续性，公司董事会审计委员会同意续聘天健会 计师事务所（特殊普通合伙）为公司2023年度审计机构，并同意将该议案提交 公司第五届董事会第二十四次会议审议。 三、总体评价 董事会审计委员会严格遵守《中华人民共和国公司法》《中华人民共和国 ...

证券代码：301092 证券简称：争光股份 公告编号：2024-018 一、授信情况概述 为满足公司及其全资子公司生产经营的资金需求，保障公司及其 全资子公司稳健运营，2024 年度公司及其全资子公司拟向银行等金 融机构申请总额不超过人民币 3 亿元（含本数）的综合授信额度，授 信种类包括但不限于银行贷款、保函、信用证、承兑汇票、票据贴现、 保理等方式融资。具体业务品种、授信额度及授信期限最终以银行及 其他金融机构实际审批为准。授权有效期限为自 2023 年年度股东大 会审议通过之日起至下一个年度股东大会授权日止。在上述期限内， 授信额度可循环使用。 为便于顺利开展向银行等金融机构申请综合授信额度事项，董事 会同时提请股东大会授权公司总经理沈建华先生在上述授信额度内 全权代表公司签署一切与授信有关的各项法律文件。授权有效期限为 自 2023 年年度股东大会审议通过之日起至下一个年度股东大会授权 日止。 浙江争光实业股份有限公司 关于公司及其全资子公司 2024 年度向银行等金融机构 申请综合授信额度的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 浙江争 ...

| 非经营性资金占用 | 资金占用方名称 | 占用方与上市公 | 上市公司核算的 | 2023年期初 | 2023年度占用累 计发生金额 | 2023年度占用 资金的利息 | 2023年度偿还累计 | 2023年期末 | 占用形成原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 司的关联关系 | 会计科目 | 占用资金余额 | （不含利息） | （如有） | 发生金额 | 占用资金余额 | | | | 控股股东、实际控制人及其附 | | | | | | | | | | 非经营性占用 | | 属企业 | | | | | | | | | | 非经营性占用 | | 小 计 | - | - | - | | | | | | | - | | 前控股股东、实际控制人及其 | | | | | | | | | | 非经营性占用 | | 附属企业 | | | | | | | | | | 非经营性占用 | | 小 计 | - | - | - | | | | | | | - | | 其他关联方及其附属企业 | | ...

目 录 | 一、审计报告……………………………………………………… 第 1—6 | | 页 | | --- | --- | --- | | 二、财务报表……………………………………………………… 第 7—14 | | 页 | | （一）合并资产负债表…………………………………………… | 第 | 7 页 | | （二）母公司资产负债表………………………………………… | 第 | 8 页 | | （三）合并利润表………………………………………………… | 第 | 9 页 | | （四）母公司利润表………………………………………………第 | | 10 页 | | （五）合并现金流量表……………………………………………第 | | 11 页 | | （六）母公司现金流量表…………………………………………第 | | 12 页 | | （七）合并所有者权益变动表……………………………………第 | | 13 页 | | （八）母公司所有者权益变动表…………………………………第 | | 14 页 | | | | 审 计 报 告 天健审〔2024〕2765 号 浙江争光实业股份有限公司全体股东： 一、审计意见 我们审计了争光实 ...

国信证券股份有限公司 关于浙江争光实业股份有限公司 2023 年度募集资金存放与使用情况的专项核查报告 国信证券保荐代表人通过与公司董事、监事、高级管理人员、内部审计、注 册会计师等人员交谈，查阅了公司内部审计工作报告、年度募集资金存放与使用 情况的专项报告、会计师出具的募集资金年度使用情况鉴证报告以及公司各项业 务和管理规章制度，从公司募集资金的管理、募集资金的用途、募集资金的信息 披露情况等方面对其募集资金制度的完整性、合理性及有效性进行了核查。 二、募集资金基本情况 （一）募集资金的到位情况 经中国证券监督管理委员会《关于同意浙江争光实业股份有限公司首次公开 发行股票注册的批复》（证监许可〔2021〕2803 号）核准，并经深圳证券交易所 同意，争光股份向社会公开发行人民币普通股 3,333.3334 万股，发行价格为每股 36.31 元，募集资金总额为 121,033.34 万元，扣除承销和保荐费用、信息披露费 用、律师费用、审计及验资费用、发行手续费用及其他费用等与发行权益性证券 直接相关的新增外部费用后，公司本次募集资金净额为 109,997.56 万元。上述募 集资金到位情况业经天健会计师事务所 ...

根据中国证券监督管理委员会《上市公司独立董事管理办法》、深圳证券交 易所《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监 管指引第 2 号——创业板上市公司规范运作》等法律法规的相关要求，浙江争光 实业股份有限公司（以下简称"公司"）董事会就公司现任独立董事金浪先生、冯 凤琴女士、肖连生先生的独立性情况进行评估并出具如下专项意见： 经核查公司现任独立董事金浪先生、冯凤琴女士、肖连生先生的任职经历以 及提交签署的相关自查文件，上述人员均未在公司担任除独立董事以外的任何职 务，也未在公司主要股东公司担任任何职务，与公司以及主要股东之间不存在利 害关系或其他可能妨碍其进行独立客观判断的关系，不存在影响独立性的情况。 综上，公司现任独立董事金浪先生、冯凤琴女士、肖连生先生均符合《上市 公司独立董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作》中对独立董事独立性的相关要求。 浙江争光实业股份有限公司 董事会关于独立董事独立性情况的专项意见 浙江争光实业股份有限公司董事会 2024 年 4 月 18 日 ...

浙江争光实业股份有限公司 2023 年度内部控制自我评价报告 浙江争光实业股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要 求（以下简称"企业内部控制规范体系"），结合浙江争光实业股份有限公司（以 下简称"公司"或"争光股份"）内部控制制度和评价办法，在内部控制日常监督和 专项监督的基础上，我们对公司截止2023年12月31日（内部控制评价报告基准日） 的内部控制有效性进行了评价。 一、重要声明 按照企业内部控制规范体系的规定，建立健全、有效的内部控制体系，如实 披露内部控制评价报告是公司董事会的责任；监事会对董事会建立和实施内部控 制进行监督；经理层负责组织领导企业内部控制的日常运行。 公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在任 何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性 承担个别及连带法律责任。 公司内部控制的目标：规范公司会计行为，保证会计资料真实、完整；堵塞 漏洞、消除隐患，防止并及时发现、纠正错误及舞弊行为，保护公司资产的安全、 完整；确保国家有关法律法规和公司内部规章制度的贯彻执行。 二、内部控制评价结论 ...